Skip to content

BridgeBio Pharma, Inc.

Boston Business Watch reported on BridgeBio Pharma, Inc. on October 7, 2026.

What we have reported

  1. October 7, 2026

    BridgeBio to Present Phase 3 Encaleret Data at Boston Bone Meeting

    BridgeBio Pharma, Inc. said on October 6, 2026 that it will present further results from its Phase 3 CALIBRATE study of encaleret at the annual meeting of the American Society for Bone and Mineral Research, held in Boston from October 9 to 12, 2026.